Apnimed, Inc. - 8-K Filing

Apnimed reports Q3 2026 net loss of $29.5 million and confirms February 28, 2027, PDUFA date for Oxnimbi. (Items: 2.02 Results of Operations and Financial Condition On November 16, 2026, Apnimed, Inc, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $APMD

Read the full article at SEC EDGAR

Part of the story LanzaTech Global, Inc. - 8-K Filing (3 articles)

More Regulatory news